Authors:
Streetman, DS
Kashuba, ADM
Bertino, JS
Kulawy, R
Rocci, ML
Nafziger, AN
Citation: Ds. Streetman et al., Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotyping, PHARMACOGEN, 11(4), 2001, pp. 349-355
Authors:
Streetman, DS
Nafziger, AN
Destache, CJ
Bertino, JS
Citation: Ds. Streetman et al., Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs, PHARMACOTHE, 21(4), 2001, pp. 443-451
Citation: Ds. Streetman et al., Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes, PHARMACOGEN, 10(3), 2000, pp. 187-216
Authors:
Streetman, DS
Bleakley, JF
Kim, JS
Nafziger, AN
Leeder, JS
Gaedigk, A
Gotschall, R
Kearns, GL
Bertino, JS
Citation: Ds. Streetman et al., Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail", CLIN PHARM, 68(4), 2000, pp. 375-383